Differential efficacy of empirical antibiotic therapy for febrile neutropenia in adolescent/young adult (AYA) and child patients.

Abstract	Survival rates in adolescent/young adult (AYA) patients with malignant diseases have improved with the introduction of pediatric-type chemotherapy; however, the higher frequency of treatment-related complications, including infections, remains a major challenge. We hypothesized that the efficacy of antibiotics may differ between AYA and younger children. We aimed to evaluate differences in the efficacy of antibiotics between them by retrospectively analyzing patients registered in previous first-line antibiotic comparative studies on febrile neutropenia (FN). Patients were classified into two groups: patients younger than 15 years of age (children group) and those aged 15 years or older (AYA group). The efficacy of antibiotic therapy was compared between groups. Success of therapy was defined as resolution of febrile episodes and clinical signs of infection within 120 h of the initiation of antibiotic therapy. A total of 818 febrile episodes in 204 patients were analyzed. Antibiotic therapy success rates were lower in the AYA group than in the children group (53.8 vs. 63.7%, P = 0.028), even when patients were restricted to those with bacteremia (11.8 vs. 41.4%, P = 0.025). However, mortality rates did not differ (0 vs. 0.5%, P = 1.000). The efficacy of first-line antibiotic therapy for FN was poorer in AYA patients than in child patients.
Authors	Hirozumi Sano, Ryoji Kobayashi, Daisuke Suzuki, Kenji Kishimoto, Daiki Hori, Satoru Matsushima, Makoto Yoshida, Takeo Sarashina, Naohisa Toriumi, Kunihiko Kobayashi
Journal	International journal of hematology (Int J Hematol) Vol. 108 Issue 5 Pg. 543-549 (Nov 2018) ISSN: 1865-3774 [Electronic] Japan
PMID	30039441 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References	Anti-Bacterial Agents
Topics	Adolescent Adult Age Factors Anti-Bacterial Agents (administration & dosage, adverse effects) Child Child, Preschool Febrile Neutropenia (blood, drug therapy, etiology) Female Humans Infant Infant, Newborn Male Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!